Carcinogenesis, Vol. 22, No. 10, 1625-1631,
October 2001
© 2001 Oxford University Press
CANCER BIOLOGY |
Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo
Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Studley Road, Heidelberg 3084 and
1 University of Melbourne Department of Medicine, Royal Melbourne Hospital, Parkville 3050, Australia
Butyrate has potent anti-tumorigenic effects on many colon cancer cell lines, including inhibition of growth and promotion of apoptosis in vitro. Nevertheless, despite the butyrate concentration in the colonic lumen being sufficient to result in the death of almost all cells in vitro, colon cancers still develop and grow in vivo, suggesting that cancer cells must develop mechanisms by which they escape the effects of butyrate observed in vitro. Insulin-like growth factor-II (IGF-II) is an autocrine growth factor in many colon cancer cells. The aim of this study was to determine whether IGF-II influences butyrate-mediated apoptosis in LIM 2405 human colon cancer cells. Butyrate and trichostatin A, both of which are histone deacetylase inhibitors although the latter is more specific, induced apoptosis as determined by floating cell counting, Hoechst 33258 staining, DNA laddering and a cell death detection ELISA. IGF-II inhibited the effects of both agents. Butyrate but not trichostatin A also induced LIM 2405 cell migration. In contrast to the above results, IGF-II enhanced butyrate-induced cell migration. Levels of IGF binding protein-3 (IGFBP-3), which may induce apoptosis by IGF-dependent or -independent mechanisms, were increased by butyrate and trichostatin A; IGF-II augmented this effect. It is therefore unlikely that IGFBP-3 mediates butyrate-induced apoptosis. We suggest that IGF-II inhibits the pro-apoptotic effect of butyrate downstream of histone deacetylase inhibition. In contrast, IGF-II promotes histone deacetylase-dependent IGFBP-3 expression and histone deacetylase-independent migration. IGF-II may promote tumour growth by mediating the development of resistance to the pro-apoptotic effects of butyrate.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Uchida, T. Maruyama, M. Ono, K. Ohta, T. Kajitani, H. Masuda, T. Nagashima, T. Arase, H. Asada, and Y. Yoshimura Histone Deacetylase Inhibitors Stimulate Cell Migration in Human Endometrial Adenocarcinoma Cells through Up-Regulation of Glycodelin Endocrinology, February 1, 2007; 148(2): 896 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J Fletcher, C T Roberts, K M Hartwich, S K Walker, and I C McMillen Somatic cell nuclear transfer in the sheep induces placental defects that likely precede fetal demise Reproduction, January 1, 2007; 133(1): 243 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Herr, O. D. Liang, J. Herrero, U. Lang, K. T. Preissner, V. K. M. Han, and M. Zygmunt Possible Angiogenic Roles of Insulin-Like Growth Factor II and Its Receptors in Uterine Vascular Adaptation to Pregnancy J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4811 - 4817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.J. Collard, M. Guy, A.J. Butt, C.M. Perks, J.M.P. Holly, C. Paraskeva, and A.C. Williams Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells Carcinogenesis, March 1, 2003; 24(3): 393 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Wilkins, K. Ohneda, T. O. Keku, A. J. D'Ercole, C. R. Fuller, K. L. Williams, and P. K. Lund Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic mice Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G457 - G464. [Abstract] [Full Text] [PDF]
|
|